France-based Lupin Dental has closed a €15 million Series A led by Fynveur, giving the company fresh capital to scale a next-generation dental robotics platform aimed at chairside procedures.
Fynveur Leads, Bpifrance Adds Loan Financing
The round, announced this week, included participation from existing shareholders and private investors, alongside additional loan financing from Bpifrance. Lupin Dental has said proceeds will fund industrialization of its robotic platform, expansion of its clinical evaluation program and commercial partnerships with dental service organizations across Europe.
Dental Robotics Enters The Autonomy Curve
Dental robotics has moved rapidly from research prototypes into commercial deployment in recent years, with autonomous drilling and guided implant systems shortening chair time and improving accuracy on high-precision procedures. The Lupin round comes as broader medical robotics continues to attract capital, echoing recent milestones like Spineart's FDA nod for PERLA TL robotic-assisted spine surgery.
France Builds Out Its Medtech Robotics Stack
Lupin Dental's Series A adds to a growing French medical robotics ecosystem backed by Bpifrance's dual-track equity-and-debt approach. The financing lands alongside broader momentum in Europe, including Motion's €2M pre-seed to rent humanoids to European factories and Pollen Robotics' $399 Microduck launch, as investors bet on Europe as a hardware-first robotics geography.
Reporting based on coverage from Tech Startups and startuphub.ai.